Ovid Therapeutics' Series B Round

Ovid Therapeutics raised a round of funding on August 11, 2015.

Ovid Therapeutics (NASDAQ: OVID) is a New York-based biopharmaceutical company using its BoldMedicine approach to develop therapies that transform the lives of patients with rare neurological diseases…

Articles about Ovid Therapeutics' Series B Round: